Influence of Exceptional Patient Characteristics on Everolimus Exposure
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: everolimus dose escalation
Sponsor: Radboud University Medical Center
Collaborators: Novartis